Department of Chemistry, Guru Jambheshwar University of Science & Technology, Hisar, Haryana, 125001, India.
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, Solan, 173229, India.
Future Med Chem. 2024;16(10):999-1027. doi: 10.4155/fmc-2023-0384. Epub 2024 May 22.
The objective of the present investigation was to design and synthesize new heterocyclic hybrids comprising benzothiazole and indenopyrazolone pharmacophoric units in a single molecular framework targeting α-amylase and α-glucosidase enzymatic inhibition. 20 new benzothiazole-appended indenopyrazoles, , were synthesized in good yields under environment-friendly conditions via cycloaddition reaction, and assessed for antidiabetic activity against α-amylase and α-glucosidase, using acarbose as the standard reference. Among all the hydroxypyrazolones, and showed the best inhibition against α-amylase and α-glucosidase, which finds support from molecular docking and dynamic studies. Compounds and have been identified as promising antidiabetic agents against α-amylase and α-glucosidase and could be considered valuable leads for further optimization of antidiabetic agents.
本研究旨在设计和合成新型杂环杂合体,这些杂合体包含苯并噻唑和茚并吡唑酮药效团单元,在单一分子框架内靶向α-淀粉酶和α-葡萄糖苷酶的抑制。通过加成反应,在环境友好条件下以良好的产率合成了 20 种新的苯并噻唑取代的茚并吡唑, ,并评估了它们对α-淀粉酶和α-葡萄糖苷酶的抗糖尿病活性,以阿卡波糖作为标准参考。在所有的羟基吡唑啉酮中, 和 对α-淀粉酶和α-葡萄糖苷酶的抑制作用最好,这一结果得到了分子对接和动力学研究的支持。化合物 和 已被确定为有希望的抗α-淀粉酶和α-葡萄糖苷酶的抗糖尿病药物,它们可以被认为是进一步优化抗糖尿病药物的有价值的先导化合物。
Curr Top Med Chem. 2023
Curr Top Med Chem. 2022
Eur J Med Chem. 2022-12-5